'Antibacterial' chemical in toothpaste could strengthen bacteria

Ana sandoiu | February 26, 2019

article image
New research finds that triclosan, a popular antibacterial chemical, could have the opposite effect and make bacteria more rather than less resilient to antibiotic treatment. Triclosan is an antibacterial compound present in everyday household and personal-care products, such as toothpaste, soap, dishwashing liquid, deodorants, kitchenware, toys, bedding, clothes, and trash bags.

Spotlight

E-zec Medical Transport Ltd

E-zec is a leading provider of high quality, fully tailored ambulance transport solutions to the NHS and private sector. Established in 1998, E-zec operates a number of fully managed transport contracts for the NHS throughout the country and provides national and European coverage for private clients and the medical insurance sector. With experience gained from millions of patients journeys, we successfully deliver a full range of patient transport solutions including:

OTHER ARTICLES

3 Big Pharma Stocks Plunging the Most During the Coronavirus Stock Market Crash: Are They Buys?

Article | March 26, 2020

Big pharma stocks have been clobbered during the coronavirus-caused stock market crash. You can count the number of drugmakers with market caps of $25 billion or more whose shares haven't dropped by double-digit percentages on one hand -- and have several fingers left over. Three big pharma stocks have plunged the most: AbbVie (NYSE:ABBV), Bristol Myers Squibb (NYSE:BMY), and Pfizer (NYSE:PFE). But are these stocks smart picks to buy right now?

Read More

5 Pharma Trends and Their Impact on Packaging

Article | February 27, 2020

The pharmaceutical industry is changing at an unprecedented pace. New biological treatments for cancer, and a dramatic rise of widespread diseases such as diabetes, call for new processing and packaging solutions to fulfill the different needs all over the world. Keep your eye on these five main packaging trends for 2020 for the global pharmaceutical market.

Read More

Five Ways to Manage Your Trial Effectively in a Fast-Changing Global Environment

Article | March 11, 2020

Over the past half-century, clinical trials have grown increasingly complex. A flood of new data from novel sources combined with more elaborate study designs and tougher regulatory standards have lengthened timelines and hiked costs, contributing to a steady decline of efficiency. It all adds up: Nearly half of all drug launches underperform revenue expectations. And if that isn’t enough, the outbreak of COVID-19 worldwide is having an effect on how life sciences companies operate their businesses, including how clinical trials are conducted. Most clinical trial research organizations have tried to adapt by tweaking a platform here, adding a new app there, but this has only yielded patchwork systems of sites, spreadsheets and dashboards that further burden the process.

Read More

Comparing HydroxyChloroquine Trials

Article | April 1, 2020

One minor side effect of the pandemic is that perhaps more people will learn about what drug research and clinical trials can really be like. Today’s example: we have a clinical trial of hydroxychloroquine from Wuhan that has just published on a preprint server. What’s good is that this one is blinded, randomized, and controlled (like the earlier hydroxychloroquine which one I blogged about here from Zhejiang University, so we can actually talk about it rather than just spend all our time wondering what the heck is going on.

Read More

Spotlight

E-zec Medical Transport Ltd

E-zec is a leading provider of high quality, fully tailored ambulance transport solutions to the NHS and private sector. Established in 1998, E-zec operates a number of fully managed transport contracts for the NHS throughout the country and provides national and European coverage for private clients and the medical insurance sector. With experience gained from millions of patients journeys, we successfully deliver a full range of patient transport solutions including:

Events